Effects of antalarmin and nadolol on the relationship between social stress and pulmonary metastasis development in male OF1 mice

Behavioural Brain Research

Volumn 205, Issue 1, 2009, Pages 200-206

  Vegas, O ^a   Garmendia, L ^a   Arregi, A ^a   Beitia, G ^a   Azpiroz, A ^a  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

Author keywords

Antalarmin; Corticosterone; HPA; IFN gamma; Nadolol; SAM; Social stress; Tumor development

Indexed keywords

ANTALARMIN; CORTICOSTERONE; GAMMA INTERFERON; NADOLOL;

AGGRESSIVENESS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; DISEASE ASSOCIATION; HISTOPATHOLOGY; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNE DEFICIENCY; IMMUNE SYSTEM; LUNG METASTASIS; LUNG PARENCHYMA; MALE; MELANOMA CELL; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SOCIAL BEHAVIOR; SOCIAL STRESS;

ADRENERGIC BETA-ANTAGONISTS; AGGRESSION; ANIMALS; CENTRAL NERVOUS SYSTEM AGENTS; CORTICOSTERONE; INTERFERON-GAMMA; LUNG; LUNG NEOPLASMS; MALE; MICE; MICE, INBRED STRAINS; NADOLOL; NEOPLASMS, EXPERIMENTAL; PYRIMIDINES; PYRROLES; RANDOM ALLOCATION; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; SOCIAL BEHAVIOR; STRESS, PSYCHOLOGICAL;

EID: 70349433569     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2009.06.033     Document Type: Article

References (76)

1. Arbiser J.L., Karalis K., Viswanathan A., Koike C., Anand-Apte B., Flynn E., et al. Corticotropin-releasing hormone stimulates angiogenesis and epithelial tumor growth in the skin. J Invest Dermatol 113 (1999) 838-842
2. Armaiz-Pena G.N., Lutgendorf S.K., Cole S.W., and Sood A.K. Neuroendocrine modulation of cancer progression. Brain Behav Immun 23 (2009) 10-15
3. Azpiroz A., De Miguel Z., Fano E., and Vegas O. Relations between different coping strategies for social stress, tumor development and neuroendocrine and immune activity in male mice. Brain Behav Immun 22 (2008) 690-698
4. Banciu M., Schiffelers R.M., Metselaar J.M., and Storm G. Utility of targeted glucocorticoids in cancer therapy. J Liposome Res 18 (2008) 47-57
5. Ben-Eliyahu S., and Shakhar G. The impact of stress, catecholamines, and the menstrual cycle on NK activity and tumor development: from in vitro studies to biological significance. In: Ader R., Cohen N., and Felten D.L. (Eds). Psychoneuroimmunology (2001), Academic Press, San Diego 545-563
6. Ben-Eliyahu S., Shakhar G., Page G.G., Stefanski V., and Shakhar K. Suppression of NK cell activity and of resistance to metastasis by stress: a role for adrenal catecholamines and beta-adrenoceptors. Neuroimmunomodulation 8 (2000) 154-164
7. Bhakoo H.S., Paolini N.S., Milholland R.J., Lopez R.E., and Rosen F. Glucocorticoid receptors and the effect of glucocorticoids on the growth of B16 melanoma. Cancer Res 41 (1981) 1695-1701
8. Black P.L., Phillips H., Tribble H.R., Pennington R., Schneider M., and Talmadge J.E. Antitumor response to recombinant murine interferon gamma correlates with enhanced immune function of organ-associated, but not recirculating cytolytic T lymphocytes and macrophages. Cancer Immunol Immunother 37 (1993) 299-306
9. Bluthe R.M., Pawlowski M., Suarez S., Parnet P., Pittman Q., Kelley K.W., et al. Synergy between tumor necrosis factor alpha and interleukin-1 in the induction of sickness behavior in mice. Psychoneuroendocrinology 19 (1994) 197-207
10. Bohm W., Thoma S., Leithauser F., Moller P., Schirmbeck R., and Reimann J. T cell-mediated, IFN-gamma-facilitated rejection of murine B16 melanomas. J Immunol 161 (1998) 897-908
11. Brain P.F., McAllister K.H., and Walmsley S.V. Drug effects on social behaviour: methods in ethopharmacology. In: Boulton A.A., Baker G.B., and Greenshaw A.J. (Eds). Neuromethods psychopharmacology (1989), The Humana Press Inc., Clifton, NJ 689-739
12. Cao L., Hudson C.A., and Lawrence D.A. Immune changes during acute cold/restraint stress-induced inhibition of host resistance to Listeria. Toxicol Sci 74 (2003) 325-334
13. Carlson K.W., Nawy S.S., Wei E.T., Sadee W., Filov V.A., Rezsova V.V., et al. Inhibition of mouse melanoma cell proliferation by corticotropin-releasing hormone and its analogs. Anticancer Res 21 (2001) 1173-1179
14. Crowley P., Lai N.Y., De Young N., Pearce P., Funder J.W., and Gill P.G. Inhibition of growth of B16 melanoma by glucocorticoids does not result directly from receptor-mediated inhibition of tumour cells. Oncology 45 (1988) 331-335
15. Cunnick J.E., Lysle D.T., Kucinski B.J., and Rabin B.S. Evidence that shock-induced immune suppression is mediated by adrenal hormones and peripheral beta-adrenergic receptors. Pharmacol Biochem Behav 36 (1990) 645-651
16. Dantzer R., Bluthè R.M., Aubert A., Goodall G., Bret-Dibat J.L., Kent S., et al. Cytokine actions on behavior. In: Rothwell N.J. (Ed). Neuroscience intelligence unit cytokines in the nervous system (1996), R. G. Landes Company, TX, USA
17. Dantzer R., Bluthé R.M., Castanon N., Chauvet N., Capuron L., Goodall G., et al. Cytokine effects on behavior. In: Ader R., Felten D.L., and Cohen N. (Eds). Psychoneuroimmunology (2001), Academic Press, San Diego 703-727
18. Dantzer R., and Kelley K.W. Stress and immunity: an integrated view of relationships between the brain and the immune system. Life Sci 44 (1989) 1995-2008
19. de Boer S.F., de Beun R., Slangen J.L., and van der Gugten J. Dynamics of plasma catecholamine and corticosterone concentrations during reinforced and extinguished operant behavior in rats. Physiol Behav 47 (1990) 691-698
20. De Boer S.F., Koopmans S.J., Slangen J.L., and Van der Gugten J. Plasma catecholamine, corticosterone and glucose responses to repeated stress in rats: effect of interstressor interval length. Physiol Behav 47 (1990) 1117-1124
21. De Souza E.B. Corticotropin-releasing factor receptors: physiology, pharmacology, biochemistry and role in central nervous system and immune disorders. Psychoneuroendocrinology 20 (1995) 789-819
22. Dobbs C.M., Vasquez M., Glaser R., and Sheridan J.F. Mechanisms of stress-induced modulation of viral pathogenesis and immunity. J Neuroimmunol 48 (1993) 151-160
23. Elenkov I.J., and Chrousos G.P. Stress hormones, proinflammatory and antiinflammatory cytokines, and autoimmunity. Ann N Y Acad Sci 966 (2002) 290-303
24. Elenkov I.J., Wilder R.L., Chrousos G.P., and Vizi E.S. The sympathetic nerve-an integrative interface between two supersystems: the brain and the immune system. Pharmacol Rev 52 (2000) 595-638
25. Gabry K.E., Chrousos G.P., Rice K.C., Mostafa R.M., Sternberg E., Negrao A.B., et al. Marked suppression of gastric ulcerogenesis and intestinal responses to stress by a novel class of drugs. Mol Psychiatry 7 (2002) 474-483 433
26. Glaser R., Kennedy S., Lafuse W.P., Bonneau R.H., Speicher C., Hillhouse J., et al. Psychological stress-induced modulation of interleukin 2 receptor gene expression and interleukin 2 production in peripheral blood leukocytes. Arch Gen Psychiatry 47 (1990) 707-712
27. Glaser R., Kiecolt-Glaser J.K., Bonneau R.H., Malarkey W., Kennedy S., and Hughes J. Stress-induced modulation of the immune response to recombinant hepatitis B vaccine. Psychosom Med 54 (1992) 22-29
28. Glaser R., Rice J., Speicher C.E., Stout J.C., and Kiecolt-Glaser J.K. Stress depresses interferon production by leukocytes concomitant with a decrease in natural killer cell activity. Behav Neurosci 100 (1986) 675-678
29. Gold P.W., and Chrousos G.P. Organization of the stress system and its dysregulation in melancholic and atypical depression: high vs low CRH/NE states. Mol Psychiatry 7 (2002) 254-275
30. Graziani G., Tentori L., Muzi A., Vergati M., Tringali G., Pozzoli G., et al. Evidence that corticotropin-releasing hormone inhibits cell growth of human breast cancer cells via the activation of CRH-R1 receptor subtype. Mol Cell Endocrinol 264 (2007) 44-49
31. Habib K.E., Weld K.P., Rice K.C., Pushkas J., Champoux M., Listwak S., et al. Oral administration of a corticotropin-releasing hormone receptor antagonist significantly attenuates behavioral, neuroendocrine, and autonomic responses to stress in primates. Proc Natl Acad Sci USA 97 (2000) 6079-6084
32. Hasegawa H., and Saiki I. Psychosocial stress augments tumor development through beta-adrenergic activation in mice. Jpn J Cancer Res 93 (2002) 729-735
33. Houghton A.N., Gold J.S., and Blachere N.E. Immunity against cancer: lessons learned from melanoma. Curr Opin Immunol 13 (2001) 134-140
34. Irwin M., Hauger R.L., Brown M., and Britton K.T. CRF activates autonomic nervous system and reduces natural killer cytotoxicity. Am J Physiol 255 (1988) R744-747
35. Jensen P., Hansen S., Moller B., Leivestad T., Pfeffer P., Geiran O., et al. Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens. J Am Acad Dermatol 40 (1999) 177-186
36. Kent S., Bluthe R.M., Kelley K.W., and Dantzer R. Sickness behavior as a new target for drug development. Trends Pharmacol Sci 13 (1992) 24-28
37. Kiecolt-Glaser J.K., McGuire L., Robles T.F., and Glaser R. Emotions, morbidity, and mortality: new perspectives from psychoneuroimmunology. Annu Rev Psychol 53 (2002) 83-107
38. Kiecolt-Glaser J.K., McGuire L., Robles T.F., and Glaser R. Psychoneuroimmunology and psychosomatic medicine: back to the future. Psychosom Med 64 (2002) 15-28
39. Kiecolt-Glaser J.K., McGuire L., Robles T.F., and Glaser R. Psychoneuroimmunology: psychological influences on immune function and health. J Consult Clin Psychol 70 (2002) 537-547
40. Konsman J.P., Parnet P., and Dantzer R. Cytokine-induced sickness behaviour: mechanisms and implications. Trends Neurosci 25 (2002) 154-159
41. Korte S.M., Beuving G., Ruesink W., and Blokhuis H.J. Plasma catecholamine and corticosterone levels during manual restraint in chicks from a high and low feather pecking line of laying hens. Physiol Behav 62 (1997) 437-441
42. Kruger-Krasagakes S., Krasagakis K., Garbe C., and Diamantstein T. Production of cytokines by human melanoma cells and melanocytes. Recent Results Cancer Res 139 (1995) 155-168
43. Kudryavtseva N.N., Bakshtanovskaya I.V., and Koryakina L.A. Social model of depression in mice of C57BL/6J strain. Pharmacol, Biochem Behav 38 (1991) 315-320
44. Lazar-Molnar E., Hegyesi H., Toth S., and Falus A. Autocrine and paracrine regulation by cytokines and growth factors in melanoma. Cytokine 12 (2000) 547-554
45. Lung H.L., Shan S.W., Tsang D., and Leung K.N. Tumor necrosis factor-alpha mediates the proliferation of rat C6 glioma cells via beta-adrenergic receptors. J Neuroimmunol 166 (2005) 102-112
46. Melamed R., Rosenne E., Shakhar K., Schwartz Y., Abudarham N., and Ben-Eliyahu S. Marginating pulmonary-NK activity and resistance to experimental tumor metastasis: suppression by surgery and the prophylactic use of a beta-adrenergic antagonist and a prostaglandin synthesis inhibitor. Brain Behav Immun 19 (2005) 114-126
47. Miller A.H., Spencer R.L., Pearce B.D., Pisell T.L., Azrieli Y., Tanapat P., et al. Glucocorticoid receptors are differentially expressed in the cells and tissues of the immune system. Cell Immunol 186 (1998) 45-54
48. Miller D.B., and O'Callaghan J.P. Neuroendocrine aspects of the response to stress. Metabolism 51 (2002) 5-10
49. Nance D.M., and Sanders V.M. Autonomic innervation and regulation of the immune system (1987-2007). Brain Behav Immun 21 (2007) 736-745
50. Nicola N.A.E. Guidebook to cytokines and their receptors (1994), Oxford University Press, Oxford
51. Nijsen M.J., Croiset G., Stam R., Bruijnzeel A., Diamant M., de Wied D., et al. The role of the CRH type 1 receptor in autonomic responses to corticotropin-releasing hormone in the rat. Neuropsychopharmacology 22 (2000) 388-399
52. Nozaki H., Hozumi K., Nishimura T., and Habu S. Regulation of NK activity by the administration of bromocriptine in haloperidol-treated mice. Brain Behav Immun 10 (1996) 17-26
53. Oka H., Emori Y., Sasaki H., Shiraishi Y., Yoshinaga K., and Kurimoto T. Anti-tumor mechanism of Z-100, an immunomodulatory Arabinomannan extracted from Mycobacterium tuberculosis strain Aoyama B, on pulmonary metastases of B16F10 melanoma: restoration of helper T cell responses via suppression of glucocorticoid-genesis. Microbiol Immunol 46 (2002) 343-351
54. Petrusz P., and Merchenthaler I. The corticotropin-releasing factor system. In: Nemeroff C.B. (Ed). Neuroendocrinology (1992), CRC Press, Boca Raton, FL 129-184
55. Ruis M.A., de Groot J., te Brake J.H., Dinand Ekkel E., van de Burgwal J.A., Erkens J.H., et al. Behavioural and physiological consequences of acute social defeat in growing gilts: effects of the social environment. Appl Anim Behav Sci 70 (2001) 201-225
56. Sanders V.M., and Straub R.H. Norepinephrine, the beta-adrenergic receptor, and immunity. Brain Behav Immun 16 (2002) 290-332
57. Schouten W.G., and Wiegant V.M. Individual responses to acute and chronic stress in pigs. Acta Physiol Scand Suppl 640 (1997) 88-91
58. Shakhar G., and Ben-Eliyahu S. In vivo beta-adrenergic stimulation suppresses natural killer activity and compromises resistance to tumor metastasis in rats. J Immunol 160 (1998) 3251-3258
59. Snyder B.K., Roghmann K.J., and Sigal L.H. Stress and psychosocial factors: effects on primary cellular immune response. J Behav Med 16 (1993) 143-161
60. Sood A.K., Bhatty R., Kamat A.A., Landen C.N., Han L., Thaker P.H., et al. Stress hormone-mediated invasion of ovarian cancer cells. Clin Cancer Res 12 (2006) 369-375
61. Stefanski V., and Ben-Eliyahu S. Social confrontation and tumor metastasis in rats: defeat and beta-adrenergic mechanisms. Physiol Behav 60 (1996) 277-282
62. Sundar S.K., Cierpial M.A., Kilts C., Ritchie J.C., and Weiss J.M. Brain IL-1-induced immunosuppression occurs through activation of both pituitary-adrenal axis and sympathetic nervous system by corticotropin-releasing factor. J Neurosci 10 (1990) 3701-3706
63. Tasker J.G., Di S., and Malcher-Lopes R. Minireview: rapid glucocorticoid signaling via membrane-associated receptors. Endocrinology 147 (2006) 5549-5556
64. Thaker P.H., Han L.Y., Kamat A.A., Arevalo J.M., Takahashi R., Lu C., et al. Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma. Nat Med 12 (2006) 939-944
65. Udelsman R., Harwood J.P., Millan M.A., Chrousos G.P., Goldstein D.S., Zimlichman R., et al. Functional corticotropin releasing factor receptors in the primate peripheral sympathetic nervous system. Nature 319 (1986) 147-150
66. Vegas O., Beitia G., Sanchez-Martin J.R., Arregi A., and Azpiroz A. Behavioral and neurochemical responses in mice bearing tumors submitted to social stress. Behav Brain Res 155 (2004) 125-134
67. Vegas O., Fano E., Brain P.F., Alonso A., and Azpiroz A. Social stress, coping strategies and tumor development in male mice: behavioral, neuroendocrine and immunological implications. Psychoneuroendocrinology 31 (2006) 69-79
68. Wang J., and Li S. Corticotropin-releasing factor family and its receptors: tumor therapeutic targets?. Biochem Biophys Res Commun 362 (2007) 785-788
69. Webster E.L., Barrientos R.M., Contoreggi C., Isaac M.G., Ligier S., Gabry K.E., et al. Corticotropin releasing hormone (CRH) antagonist attenuates adjuvant induced arthritis: role of CRH in peripheral inflammation. J Rheumatol 29 (2002) 1252-1261
70. Webster E.L., Lewis D.B., Torpy D.J., Zachman E.K., Rice K.C., and Chrousos G.P. In vivo and in vitro characterization of antalarmin, a nonpeptide corticotropin-releasing hormone (CRH) receptor antagonist: suppression of pituitary ACTH release and peripheral inflammation. Endocrinology 137 (1996) 5747-5750
71. Webster J.I., Tonelli L., and Sternberg E.M. Neuroendocrine regulation of immunity. Annu Rev Immunol 20 (2002) 125-163
72. Wu W., Chaudhuri S., Brickley D.R., Pang D., Karrison T., and Conzen S.D. Microarray analysis reveals glucocorticoid-regulated survival genes that are associated with inhibition of apoptosis in breast epithelial cells. Cancer Res 64 (2004) 1757-1764
73. Wu W.J., and Pruett S.B. Suppression of splenic natural killer cell activity in a mouse model for binge drinking. II. Role of the neuroendocrine system. J Pharmacol Exp Ther 278 (1996) 1331-1339
74. Xu B. The importance of beta-adrenergic receptors in immune regulation: a link between neuroendocrine and immune system. Med Hypotheses 56 (2001) 273-276
75. Yang Y., Park H., Kim T.S., Bang S.I., and Cho D. Enhancement of cell migration by corticotropin-releasing hormone through ERK1/2 pathway in murine melanoma cell line, B16F10. Exp Dermatol 16 (2007) 22-27
76. Yokotani K., Murakami Y., Okada S., and Hirata M. Role of brain arachidonic acid cascade on central CRF1 receptor-mediated activation of sympatho-adrenomedullary outflow in rats. Eur J Pharmacol 419 (2001) 183-189